Avandia will remain on the U.S. market, but be tightly restricted due to heart risk concerns, says the Food and Drug Administration.
Yahoo! Buzz US: Top Stories, Yahoo Buzz: Business
Thu, 09/23/2010 - 9:13am
Avandia will remain on the U.S. market, but be tightly restricted due to heart risk concerns, says the Food and Drug Administration.